You are given a text that consists of multiple sentences. Your task is to perform abstractive summarization on this text. Use your understanding of the content to express the main ideas and crucial details in a shorter, coherent, and natural sounding text.

LONDON--(BUSINESS WIRE)-- Ap27 FORM 38.5(b) - Amendment to Sales IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY 1. KEY INFORMATION 24 November 2020 2. INTERESTS AND SHORT POSITIONS a. Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2) ORD Interests Short Positions Number (%) Number (%) (1) 4,291 0.01% 143,893 0.23% (2) 127,760 0.20% 0 0.00% (3) 0 0.00% 0 0.00% 132,051 0.21% 143,893 0.23% b. Interests and short positions in relevant securities of the company, otherthan the class dealt in (Note 2) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total Ap28 3. DEALINGS (Note 3) a. Purchases and sales Class of relevant Number of security securities US$0.01 ordinary shares 88 US$0.01 ordinary shares 88 b. Derivatives transactions (other than options transactions) Product name, e.g. CFD Nature of transaction (Note 5) Number of relevant securities (Note 6) Price per unit (Note 4) c. Options transactions in respect of existing relevant securities i. Writing, selling, purchasingor varying Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 4) ii. Exercising Product name, e.g. call option Number of securities Exercise price per unit (Note 4) d. Other dealings (including transactions in respect of new securities) (Note 3) Nature of transaction (Note 7) Details Price per unit (if applicable) (Note 4) Ap29 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. None 27 Nov 2020 Large Holdings Regulatory Operations 020 3134 7213

Answer: Form 38.5(b) - Osmotica Pharmaceuticals Plc Amendment